Minalrestat
Minalrestat (ARI-509) is an orally active and potent aldose reductase inhibitor for the study of impaired microvascular reactivity in diabetic patients.
Product Specifications
CAS Number
129688-50-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.2
Molecular Formula
C19H11BrF2N2O4
Notes
Research use only, not for human use.
Receptor
Reductase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1072154-01 0.02 mg (E-Coli)
Recombinant Clostridium botulinum Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details 
MBS1072154-02 0.1 mg (E-Coli)
Recombinant Clostridium botulinum Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details 
MBS1072154-03 0.02 mg (Yeast)
Recombinant Clostridium botulinum Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details MBS1072154-04 0.1 mg (Yeast)
Recombinant Clostridium botulinum Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details 
MBS1072154-05 0.02 mg (Baculovirus)
Recombinant Clostridium botulinum Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details MBS1072154-06 0.02 mg (Mammalian-Cell)
Recombinant Clostridium botulinum Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details